echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Teyi Pharmaceutical's sulfadiazine tablets passed the consistency evaluation for the first time

    Teyi Pharmaceutical's sulfadiazine tablets passed the consistency evaluation for the first time

    • Last Update: 2021-03-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On February 22, Teyi Pharmaceutical issued an announcement stating that the "Sulfadiazine Tablets" "Drug Supplementary Application Approval Notice" was recently approved and issued by the State Food and Drug Administration, and the notification number: 2021B00293.


    Data show that sulfadiazine is a moderately effective sulfonamide, which is effective against non-enzyme producing Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, Escherichia coli, Klebsiella, Salmonella, Shigella and other Enterobacteriaceae Bacteria, Neisseria gonorrhoeae, meningococcus and Haemophilus influenzae have antibacterial effects.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.